Evommune (EVMN) Cash & Equivalents (QoQ) (2024 - 2026)

Evommune (EVMN) Cash & Equivalents (QoQ) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,921.77 Bn	66,921.49 Bn	-
2	Nanobiotix	1,911.83 Bn	1,911.77 Bn	-
3	Akari Therapeutics	959.56 Bn	959.56 Bn	-
4	BeOne Medicines	471.57 Bn	466.77 Bn	1.35 Bn
5	Vertex Pharmaceuticals	122.01 Bn	114.76 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.09 Bn	61.34 Bn	3.31 Bn
7	Belite Bio	62.68 Bn	62.68 Bn	-
8	Argenx Se	55.86 Bn	50.68 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.48 Bn	34.47 Bn	959.66 Mn
10	Evommune	389.23 Mn	177.76 Mn	-

Download Data